BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 20375988)

  • 21. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
    Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
    J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
    Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy.
    Xie K; Xu C; Zhang M; Wang M; Min L; Qian C; Wang Q; Ni Z; Mou S; Dai H; Pang H; Gu L
    Cell Death Dis; 2019 Dec; 10(12):915. PubMed ID: 31801948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation.
    Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R
    Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Huangkui capsule alleviates doxorubicin-induced proteinuria via protecting against podocyte damage and inhibiting JAK/STAT signaling.
    Zhao L; Han S; Chai C
    J Ethnopharmacol; 2023 Apr; 306():116150. PubMed ID: 36608778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.
    Pereira RL; Buscariollo BN; Corrêa-Costa M; Semedo P; Oliveira CD; Reis VO; Maquigussa E; Araújo RC; Braga TT; Soares MF; Moura IC; Malheiros DM; Filho AP; Keller AC; Câmara NO
    Kidney Int; 2011 Jun; 79(11):1217-27. PubMed ID: 21412216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3β-TFEB axis.
    Hou B; Li Y; Li X; Zhang C; Zhao Z; Chen Q; Zhang N; Li H
    Cell Signal; 2020 Nov; 75():109744. PubMed ID: 32827692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.
    Yuan Y; Huang S; Wang W; Wang Y; Zhang P; Zhu C; Ding G; Liu B; Yang T; Zhang A
    Kidney Int; 2012 Oct; 82(7):771-89. PubMed ID: 22648295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of slit diaphragm proteins NEPHRIN and NEPH1 upon binding of HGF promotes podocyte repair.
    Solanki AK; Arif E; Srivastava P; Furcht CM; Rahman B; Wen P; Singh A; Holzman LB; Fitzgibbon WR; Budisavljevic MN; Lobo GP; Kwon SH; Han Z; Lazzara MJ; Lipschutz JH; Nihalani D
    J Biol Chem; 2021 Sep; 297(3):101079. PubMed ID: 34391780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR-α transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice.
    Mori K; Mukoyama M; Nakao K
    Kidney Int; 2011 Jun; 79(12):1274-6. PubMed ID: 21625258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractalkine deficiency attenuates LPS-induced acute kidney injury and podocyte apoptosis by targeting the PI3K/Akt signal pathway.
    Gong Q; Ma J; Kang H; Pan X; You Y
    Clin Exp Nephrol; 2022 Aug; 26(8):741-749. PubMed ID: 35394554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IP
    Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
    BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protective effect of the EP2 receptor on TGF-β1 induced podocyte injury via the PI3K / Akt signaling pathway.
    Liu J; Zhang YD; Chen XL; Zhu XL; Chen X; Wu JH; Guo NF
    PLoS One; 2018; 13(5):e0197158. PubMed ID: 29746568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells.
    Usatyuk PV; Fu P; Mohan V; Epshtein Y; Jacobson JR; Gomez-Cambronero J; Wary KK; Bindokas V; Dudek SM; Salgia R; Garcia JG; Natarajan V
    J Biol Chem; 2014 May; 289(19):13476-91. PubMed ID: 24634221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.
    Kim SI; Lee SY; Wang Z; Ding Y; Haque N; Zhang J; Zhou J; Choi ME
    J Am Soc Nephrol; 2014 Sep; 25(9):1966-78. PubMed ID: 24652804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
    Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
    Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.